Minimal residual disease is a significant predictor of treatment failure in B lineage adult ALL: final results of the international trial UKALL XII:ECOG 2993

Gelijkaardige items

• Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993.
  door: Patel, B, et al.
  Gepubliceerd in: (2010)
• The outcome of 551 1(st) CR transplants in adult ALL from the UKALL XII/ECOG 2993 study
  door: Goldstone, A, et al.
  Gepubliceerd in: (2004)
• Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
  door: Sive, J, et al.
  Gepubliceerd in: (2012)
• The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study
  door: Patel, B, et al.
  Gepubliceerd in: (2005)
• Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.
  door: Lazarus, H, et al.
  Gepubliceerd in: (2006)